Identification and development of oxoquinazoline derivatives as novel mycobacterial inhibitors targeting cell wall synthesis enzyme
Biomedical and Biotechnology Research Journal (BBRJ) · 2018
DOI: 10.4103/bbrj.bbrj_101_17 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical and Biotechnology Research Journal (BBRJ), 2018. Verfasst von Dhramarajan Sriram und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Tuberculosis (TB) still remains the leading cause of death worldwide and was unanswered till date. Available treatment strategies have many drawbacks such as longer treatment period, side effects, and drug interactions, which result in patient noncompliance. In the present work, we thrived to develop inhibitors against unexplored key target glutamate racemase.
Methods
Lead was identified from in-house database using differential scanning fluorimetry, inhibitors were developed by lead derivatization technique and evaluated them by various biological assays.
Results
In oxoquinazoline series, compounds 18 (10.1 ± 0.62 μM) and 22 (5.23 ± 0.34 μM) were found to be the most promising potent inhibitors among all. These compounds also showed their inhibition on replicating and nonreplicating bacteria.
Conclusion
Our attempt to develop the potent novel inhibitors against Mycobacterium tuberculosis resulted in developing few promising inhibitors, yet these compounds need further studies to answer all questions in drug discovery. Further optimization of compounds can result in still better compounds for treating TB.
Zitieren
APA
Sriram, D., Malapati, P., & Vagolu, K. (2018). Identification and development of oxoquinazoline derivatives as novel mycobacterial inhibitors targeting cell wall synthesis enzyme. Biomedical and Biotechnology Research Journal (BBRJ). https://doi.org/10.4103/bbrj.bbrj_101_17
Vancouver
Sriram D, Malapati P, Vagolu K. Identification and development of oxoquinazoline derivatives as novel mycobacterial inhibitors targeting cell wall synthesis enzyme. Biomedical and Biotechnology Research Journal (BBRJ). 2018. doi:10.4103/bbrj.bbrj_101_17
BibTeX
@article{Sriram2018,
author = {Sriram, Dhramarajan and Malapati, Prasanthi and Vagolu, KrishnaSiva},
title = {Identification and development of oxoquinazoline derivatives as novel mycobacterial inhibitors targeting cell wall synthesis enzyme},
journal = {Biomedical and Biotechnology Research Journal (BBRJ)},
year = {2018},
doi = {10.4103/bbrj.bbrj_101_17}
}
EUVIMED